EOC: EOC Pharma completes patient recruitment in phase I study of efti to treat metastatic breast cancer

Immutep Limited has been informed its Chinese partner, EOC Pharma, has completed patient recruitment for the ongoing EOC202A1101 study being conducted in China. EOC Pharma is an oncology